Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study
Background. Recently, there is a lack of studies comparing the renoprotective effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. This study therefore aimed to investigate the renoprotective effects of SGLT-2 inhibitors and DPP-4 inhibitors on...
Saved in:
Main Authors: | Apichaya Chanawong (Author), Suriyon Uitrakul (Author), Supatcha Incomenoy (Author), Natnicha Poonchuay (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021) -
Research advances on renoprotective mechanism of SGLT-2 inhibitors in non-diabetic kidney disease
by: Feng Liu, et al.
Published: (2023) -
Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy
by: Anuj Kumar Borah, et al.
Published: (2022) -
Cost Analysis of DPP4 and SGLT2 Inhibitors - "Dilemma of the Prescribing Physician - Which Brand to Choose?"
by: Hiteswar Saikia, et al.
Published: (2024) -
Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review
by: Angelika Buczyńska, et al.
Published: (2024)